Ioana Hrab

Caen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation.

Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation.

Journal: Neuro-oncology

Published: July 22, 2025

Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: an international cross-sectional investigation.

Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: an international cross-sectional investigation.

Journal: Neuro-oncology

Published: March 24, 2025

Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study.

Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 10, 2024

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.

Journal: Frontiers in oncology

Published: November 22, 2022

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.

Journal: BMC cancer

Published: July 08, 2022

Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib.

Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib.

Journal: Oncology letters

Published: June 04, 2021

Efficacy and Safety of Weekly Paclitaxel in Breast Cancer With Symptomatic Bone Marrow Infiltration.

Efficacy and Safety of Weekly Paclitaxel in Breast Cancer With Symptomatic Bone Marrow Infiltration.

Journal: Anticancer research

Published: April 10, 2020

Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial.

Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial.

Journal: BMC cancer

Published: December 06, 2019

REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours.

REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 28, 2015

How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.

How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: April 22, 2015

REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours.

REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 03, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026